Tag: vendor remediation

Documenting Issue Escalation & Remediation for Audits, Health Authority Queries and Due Diligence Documenting Issue Escalation & Remediation for Audits, Health Authority Queries and Due Diligence In the realm of clinical trials, particularly within the complex frameworks of biosimilar clinical trials, timely and effective issue escalation and remediation processes are critical. This comprehensive guide details…

Read More “Documenting Issue Escalation & Remediation for Audits, Health Authority Queries and Due Diligence” »

Digital Tools and Automation That Transform Issue Escalation & Remediation in Clinical Development Digital Tools and Automation That Transform Issue Escalation & Remediation in Clinical Development Clinical trials play a critical role in advancing medical knowledge and developing new therapies. However, the complexities involved in clinical development often lead to unexpected issues that require escalation…

Read More “Digital Tools and Automation That Transform Issue Escalation & Remediation in Clinical Development” »

Case Studies: Issue Escalation & Remediation That Rescued High-Risk Studies and Vendors Case Studies: Issue Escalation & Remediation That Rescued High-Risk Studies and Vendors In the complex landscape of clinical trials, the risk of challenges arising is ever-present. Issues ranging from regulatory non-compliance to vendor performance failures can jeopardize study timelines and integrity. This tutorial…

Read More “Case Studies: Issue Escalation & Remediation That Rescued High-Risk Studies and Vendors” »

Integrating Issue Escalation & Remediation With QMS, Risk Registers and Governance Committees Integrating Issue Escalation & Remediation With QMS, Risk Registers and Governance Committees The clinical research landscape is invariably complex, necessitating stringent oversight and robust operational protocols to ensure trial integrity and compliance. This guide delineates a comprehensive approach to integrating issue escalation and…

Read More “Integrating Issue Escalation & Remediation With QMS, Risk Registers and Governance Committees” »

Future-Proofing Issue Escalation & Remediation for AI, Real-World Data and Platform Trials Future-Proofing Issue Escalation & Remediation for AI, Real-World Data and Platform Trials As the landscape of clinical trials evolves with advancements in technology such as artificial intelligence, real-world evidence, and platform trials, the need for effective issue escalation and remediation processes becomes increasingly…

Read More “Future-Proofing Issue Escalation & Remediation for AI, Real-World Data and Platform Trials” »

Aligning Issue Escalation & Remediation With ICH E6(R3), GCP and Quality-by-Design Principles Aligning Issue Escalation & Remediation With ICH E6(R3), GCP and Quality-by-Design Principles In the dynamic field of clinical research, ensuring that issue escalation and remediation processes are effectively aligned with ICH E6(R3) guidelines, Good Clinical Practice (GCP), and Quality-by-Design (QbD) principles is paramount….

Read More “Aligning Issue Escalation & Remediation With ICH E6(R3), GCP and Quality-by-Design Principles” »

Issue Escalation & Remediation Checklists for Clinical Operations and Vendor Governance Teams Issue Escalation & Remediation Checklists for Clinical Operations and Vendor Governance Teams In today’s highly regulated environment of clinical trials, managing issues effectively within clinical operations and vendor governance is crucial. The integrity of clinical data, participant safety, and regulatory compliance all hinge…

Read More “Issue Escalation & Remediation Checklists for Clinical Operations and Vendor Governance Teams” »

Common Pitfalls in Issue Escalation & Remediation—and How to Avoid Regulatory Findings Effective issue escalation and remediation are critical components in managing clinical trials, especially in the highly regulated environments of the US, UK, and EU. In particular, professionals involved in ankylosing spondylitis clinical trials need to be acutely aware of the nuances associated with…

Read More “Common Pitfalls in Issue Escalation & Remediation—and How to Avoid Regulatory Findings” »

Using KPIs and SLAs to Optimize Issue Escalation & Remediation Across CROs and Service Providers Using KPIs and SLAs to Optimize Issue Escalation & Remediation Across CROs and Service Providers Understanding Key Performance Indicators (KPIs) and Service Level Agreements (SLAs) In clinical research operations, Key Performance Indicators (KPIs) and Service Level Agreements (SLAs) are essential…

Read More “Using KPIs and SLAs to Optimize Issue Escalation & Remediation Across CROs and Service Providers” »

Issue Escalation & Remediation for Decentralized, Hybrid and Data-Heavy Clinical Trials Issue Escalation & Remediation for Decentralized, Hybrid and Data-Heavy Clinical Trials In the rapidly evolving landscape of clinical research, particularly with the rise of decentralized and hybrid clinical trials, the importance of effective issue escalation and remediation strategies cannot be overstated. This article provides…

Read More “Issue Escalation & Remediation for Decentralized, Hybrid and Data-Heavy Clinical Trials” »